This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Universal flu vaccine aims to block all flu strains
Biotech firms pursue a universal vaccine that targets stable flu components to combat bird flu and seasonal flu. Dynavax reports mice and baboon data from Vienna and envisions a shot every three years plus a standard mutating-protein vaccine. Vical San Diego and the University of Bath pursue mutation resistant antiviral drugs and complementary treatments.
MENTIONED IN THIS ARTICLE
Hong Kong
Anthony Fauci
National Institute For Allergy and Infectious Diseases
International Federation of Pharmaceutical Manufacturers & Associations
Dynavax Technologies
Berkeley
Calif
Dynavax
Vienna
Gary van Nest
Vical
San Diego
University of Bath
England
Gilead Sciences
San Jose Mercury News
Dorice Yalda